ALLERGAN INC
4, 1996-08-07
PHARMACEUTICAL PREPARATIONS
Previous: THERMADYNE HOLDINGS CORP /DE, 10-Q, 1996-08-07
Next: ALTERNATIVE ASSET GROWTH FUND L P, 10-Q, 1996-08-07



U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 4
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check box if no longer subject to Section 16. 
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Herbert, Gavin S.
   Allergan, Inc.
   2525 Dupont Drive
   Irvine, CA  92612
   U.S.A.
2. Issuer Name and Ticker or Trading Symbol
   Allergan, Inc.
   AGN
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   July 1996
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person to Issuer (Check all applicable)
   (X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other 
   (specify below)
   
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Year      |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock               |5/2/96|J (1| |24,518            |A  |$20.00     |                   |I     |By Trust (2)               |
                           |      |)   | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/24/9|S   | |13,017            |D  |$40.25     |                   |I     |By Trust (2)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/24/9|S   | |6,983             |D  |$40.125    |                   |I     |By Trust (2)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/25/9|S   | |4,500             |D  |$41.25     |                   |I     |By Trust (2)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/25/9|S   | |3,900             |D  |$41.125    |                   |I     |By Trust (2)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/25/9|S   | |1,600             |D  |$41.00     |235,522            |I     |By Trust (2)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/25/9|S   | |4,500             |D  |$41.125    |                   |I     |By Trust (3)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/25/9|S   | |500               |D  |$41.25     |41,470             |I     |By Trust (3)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |7/24/9|S   | |7,100             |D  |$40.25     |43,970             |I     |By Trust (4)               |
                           |6     |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |      |    | |                  |   |           |1,500              |D     |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock               |      |    | |                  |   |           |2,000              |I     |By Spouse                  |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Year        |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Employee Stock Option |$20.00  |5/2/9|J (1| |24,518     |D  |(5)  |6/24/|Common Stock|24,518 |       |290,374     |D  |            |
(right to buy) with ta|        |6    |)   | |           |   |     |96   |            |       |       |            |   |            |
ndem tax withholding r|        |     |    | |           |   |     |     |            |       |       |            |   |            |
ight                  |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  Exercise of in-the-money derivative security pursuant to an old Rule 16b-3 
Plan.  Column 9 represents all stock options outstanding as of 7/31/96.
(2)  Shares held by the Herbert Family Trust.  Reporting person is trustee and 
beneficiary and has the power to revoke without another's consent.
(3)  Shares held by the Marilyn Hausman Successor Trust.  Reporting person is 
co-trustee and has a pecuniary interest under the rules.
(4)  Shares held by the Gavin Herbert Jr. Successor Trust.  Reporting person is 
co-trustee and has a pecuniary interest under the rules.
(5)  Granted pursuant to the Allergan, Inc. 1989 Incentive Compensation Plan, 
which complies with old Rule 16b-3; the option became exercisable in 
25% increments on 6/24/87, 6/24/88, 6/24/89 and 
6/24/90.
SIGNATURE OF REPORTING PERSON
/s/ Gavin S. Herbert
DATE
8/6/96



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission